Next Article in Journal
Modeling of Nonlinear Dynamic Processes of Human Movement in Virtual Reality Based on Digital Shadows
Next Article in Special Issue
A Parallel Computing Approach to Gene Expression and Phenotype Correlation for Identifying Retinitis Pigmentosa Modifiers in Drosophila
Previous Article in Journal
Development of Mathematical Model to Predict Soymilk Fouling Deposit Mass on Heat Transfer Surfaces Using Dimensional Analysis
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Computation
Volume 11
Issue 4
10.3390/computation11040084
computation-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Computational Methods in the Drug Delivery of Carbon Nanocarriers onto Several Compounds in Sarraceniaceae Medicinal Plant as Monkeypox Therapy

by
Fatemeh Mollaamin
Department of Biology, Faculty of Science, Kastamonu University, Kastamonu 37100, Turkey
Computation 2023, 11(4), 84; https://doi.org/10.3390/computation11040084
Submission received: 15 February 2023 / Revised: 29 March 2023 / Accepted: 17 April 2023 / Published: 20 April 2023
(This article belongs to the Special Issue Computational Biology and High-Performance Computing)
Browse Figures
Versions Notes

Abstract

In this article, monkeypox is studied as a zoonotic poxvirus disease which can occur in humans and other animals due to substitution of the amino acid serine with methionine. We investigate the (+)-catechin, betulinic acid, ursolic acid, quercetin-3-O-galactoside, luteolin-7-O-glucoside, and myricetin in Sarracenia purpurea drugs from Sarraceniaceae family for treating monkeypox disease. This is performed via adsorption onto the surface of (6,6) armchair single-walled carbon nanotube (SWCNT) at the B3LYP/6-311+G (2d,p) level of theory in a water medium as the drug delivery method at 300 K. Sarracenia purpurea has attracted much attention for use in the clinical treatment of monkeypox disease due to the adsorption of its effective compounds of (+)-catechin, betulinic acid, ursolic acid, quercetin-3-O-galactoside, luteolin-7-O-glucoside, and myricetin onto the surface of (6,6) armchair SWCNT, a process which introduces an efficient drug delivery system though NMR, IR and UV-VIS data analysis to the optimized structure. In addition to the lowering of the energy gap (∆E = E LUMO − EHOMO), HOMO–LUMO energy has illustrated the charge transfer interactions taking place within (+)-catechin, betulinic acid, ursolic acid, quercetin-3-O-galactoside, luteolin-7-O-glucoside, and myricetin. The atomic charges have provided the proper perception of molecular theory and the energies of fundamental molecular orbitals.

Graphical Abstract

1. Introduction

The Monkeypox virus can cause infectious diseases in the human body and sometimes in other animals. The virus causes the symptoms of muscle ache, swollen lymph nodes, and pimples accompanying a fever that produces smallpox, which peels little by little until disappearing [1]. Over a period of several weeks, the symptoms become weaker, but sometimes are strong, especially in people with vulnerable health [1,2,3].This virus causes a type of chickenpoxis orthopoxvirus and may be distributed due to bush meat, animal scrapes or stings, bodily liquids, contaminated ingredients or sick people through the air or droplets [4,5]. In 2014, Minasov and co-workers discovered the crystal structure of A42R profilin-like protein from the Monkeypox virus using X-ray diffraction [6]. It was seen that the amino acid of serine in the target of L-PEPTIDE LINKING, which has the formula C5H11NO2Se from the A42R profilin-like protein, was substituted with methionine, a fact which has been shown by MSE protein MSE (1), MSE (75), MSE (82), and MSE (107) in two chains of A and B with (Scheme 1).
Although there is no cure for the monkeypox disease, the smallpox vaccine could be efficient in preventing putrefaction in close connections and in reducing the hardness of the disease. During spread, some antiviral medications and chemical drugs might be applied, as might the smallpox vaccine [7,8]. Moreover, medicinal plants and herbal practices have been used to treat viral diseases for decades. Although rarely studied, these medicinal plants could serve as strong foundations for novel antiviral drugs with applications versus rising and increasing viral diseases such as monkeypox, smallpox, yellow fever, Lassa fever, meningitis, and COVID-19.
A research work by Arndt and his co-workers demonstrated the in vitro characterization of Sarracenia purpurea to be the first effective inhibitor of poxvirus replication at the level of early viral transcription. With the renewed threat of poxvirus-related infections, their results showed that Sarracenia purpurea might act as another defensive measure against orthopoxvirus infections [9].
Recently, scientists indicated the potential of scarcely investigated and uninvestigated natural drugs when applied to curing COVID-19, yellow fever, smallpox, monkeypox, hepatitis, poliomyelitis, Lassa fever, and meningitis [10]. Understanding disease ecology could help to preventing transmission and curb its spread. The established treatment protocols along with the development of new antiviral agents and vaccines could play a pivotal role in controlling transmission.
Abubakar and his research group aimed to document the herbal practices and medicinal plants used to treat monkeypox and other emerging and re-emerging viral diseases [11].
In this work, we have investigated the physico-chemical characteristics of effective compounds of the medicinal plant, Sarracenia purpurea, including (+)-catechin, betulinic acid, ursolic acid, quercetin-3-O-galactoside, luteolin-7-O-glucoside, and myricetin. This plant is employed to treat smallpox, cowpox and monkeypox.
It has been investigated that Sarracenia purpurea can be an inhibitor of the orthopoxvirus protein, a fact which is exhibited by its being the cure for human smallpox disease. The impact of Sarracenia purpurea might decrease in patients with impaired immune systems [12,13].
There is a focus on enhancing the bioavailability and duration of action of a drug in order to modify its therapeutic effect. Drug delivery technique is able to change a drug’s pharmacokinetics and specificity by formulating it with various ingredients, drug carriers, and pieces of medical equipment [14,15,16,17,18]. Nanomedicine in drug delivery can achieve the improved delivery of water insoluble drugs, the delivery of large macromolecule drugs to intracellular sites of action, and the codelivery of two or more drugs or therapeutic agents for use in combination remedy [19,20,21].
Nanotubes, with their intrinsic properties, have been considered potential candidates for drug delivery carriers. The capped ends of nanotubes may be opened up by oxidation, allowing for the insertion of molecules of interest inside the nanotubes. Carbon nanotubes (CNTs) can easily penetrate cells, delivering drugs directly to the cytoplasm or nucleus. Nanotubes conform to a perpendicular position to the cell membrane during uptake, perforating and diffusing through the lipid bilayer to enter the cytoplasm. Functionalized CNTs are easily internalized by cells through passive and endocytosis-independent mechanisms [22,23,24,25,26,27].
In this research, we have focused on (+)-catechin, betulinic acid, ursolic acid, quercetin-3-O-galactoside, luteolin-7-O-glucoside, and myricetin, adsorbed onto the surface of (6,6) armchair SWCNT in a water medium for preventing the activity of the monkeypox virus (Scheme 2).
The structure of (+)-catechin, betulinic acid, ursolic acid, quercetin-3-O-galactoside, luteolin-7-O-glucoside, and myricetin in the Sarracenia purpurea medicinal plant (a carnivorous plant in the Sarraceniaceae family) has been investigated in this study as a relatively stable drug for adsorption onto the surface of (6,6) armchair SWCNT through the drug delivery method (Scheme 2). Thus, a series of quantum theoretical approaches, including DFT methods, has been used in order to find the optimized coordination of (+)-catechin, betulinic acid, ursolic acid, quercetin-3-O-galactoside, luteolin-7-O-glucoside, and myricetin, adsorbed onto (6,6) armchair SWCNT by using Gaussian 16 revision C.01 program (Scheme 2) [28]. The adsorption of these compounds onto (6,6) armchair SWCNT has indicated the nature of chemisorption for the bond distance of O–C of about 1.5 Å, with the equilibrium electron diffusion of effective compounds of Sarracenia purpurea (adsorbate) and single-walled carbon nanotube (adsorbent) (Scheme 2).

2. Theoretical Frameworks and Computational Methods

The geometric optimization of the compounds in this paper has been performed via the framework of DFT using the three-parameter Becke’s exchange [29] and Lee–Yang–Parr’s correlation non-local functional [30], usually known as the B3LYP method and basis set of 6-311+G(2d,p). The density functional theory (DFT) is one of the most employed approximations of Hohenberg, Kohn and Sham and allows the theoretical study of material properties [31]. Density functional theory (DFT) represents an advantageous methodology for estimating chemical systems, and discovering its similarities and differences to other computational employed methodologies is of importance [32,33].
Therefore, the electronic structure of adsorbed (6,6) armchair CNT by (+)-catechin, betulinic acid, ursolic acid, quercetin-3-O-galactoside, luteolin-7-O-glucoside, and myricetin in the Sarracenia purpurea medicinal plant has been illustrated for use measuring physico-chemical properties (Scheme 2).
In this work, the Onsager model has been used. This was developed by Frisch, Wong and Wiberg and utilizes spherical cavities. Even though this implies a less accurate description of the solute–solvent interface, this approximation simplifies the evaluation of energy formatives in geometry optimizations and frequency analysis. Moreover, Cramer and Truhlar improved this model at the dipole level [34,35,36,37,38]. In fact, a cavity must have a physical sense, such as in the Onsager model, and a mathematical ability, as often demonstrated in other descriptions of solvent impacts [39]. On the other hand, the cavity has to keep out the solvent, including its frontiers, as the largest probability part of the solute charge distribution [39,40,41,42,43].
Basically, a group of quantum theoretical methods has been performed to explore some physical and chemical properties from optimized structure of (+)-catechin, betulinic acid, ursolic acid, quercetin-3-O-galactoside, luteolin-7-O-glucoside, and myricetin in Sarracenia purpurea medicinal plant, adsorbed onto the surface of (6,6) armchair CNT. This includes charge distribution, thermodynamic calculations and nuclear magnetic resonance analysis due to designing a drug delivery model using Gaussian 16 revision C.01 program [28]. Moreover, the gauge-including atomic orbitals (GIAO) have been adopted to solve the gauge problem in the calculation of nuclear magnetic shielding for [(+)-catechin, betulinic acid, ursolic acid, quercetin-3-O-galactoside, luteolin-7-O-glucoside, and myricetin in Sarracenia purpurea, adsorbed onto the surface of (6,6) armchair CNT using density functional theory (DFT) calculation.

3. Results and Discussion

CNTs or carbon nanotubes describe drug delivery platforms that may be functionalized with various biomolecules containing antibodies, proteins, and DNA. This permits the particular target to transferring the special tissues, organs, or cells. Thus, these compounds can easily penetrate cells, delivering drugs directly to the cytoplasm or nucleus. Drug delivery systems improve the pharmacological and therapeutic profile and efficacy of the drug in question and lower the occurrence of off-target outcomes.

3.1. Nuclear Magnetic Resonance Data

The NMR data of isotropic (σiso) and anisotropic shielding tensor (σaniso), as well as the eigenvalues of chemical shielding including σ11, σ22, and σ33 (ppm) for (+)-catechin, betulinic acid, ursolic acid, quercetin-3-O-galactoside, luteolin-7-O-glucoside, and myricetin in the Sarracenia purpurea medicinal plant, adsorbed onto the surface of (6,6) armchair SWCNT, respectively, have been estimated (Table 1).
The computed results exhibited the SCF GIAO magnetic shielding tensor in ppm for hydrogen, carbon, and oxygen and explored the active site of (+)-catechin, betulinic acid, ursolic acid, quercetin-3-O-galactoside, luteolin-7-O-glucoside, and myricetin in Sarracenia purpurea as the drug for the treatment of the monkeypox disease. The calculations were accomplished based on the B3LYP/6-311+G (2d,p) level of theory using Gaussian 16 revision C.01 program [28] and are reported in Table 1.
The (+)-catechin, betulinic acid, ursolic acid, quercetin-3-O-galactoside, luteolin-7-O-glucoside, and myricetin in Sarracenia purpurea medicinal plant, adsorbed onto the (6,6) armchair CNT, showed chemical shielding including σ11, σ22, σ33, σiso, and σaniso (ppm) for various atoms of hydrogen, carbon, and oxygen in the active sites of the molecules through the NMR graphs (Figure 1a–f,a’–f’). The most fluctuations of atomic charge and chemical shielding were observed in O10, O19 ((+)-catechin), O16, O32, and O33 (betulinic acid), O3, O32, and O33 (ursolic acid), O10, O17, and O19 (quercetin-3-O-galactoside), O16, O18, O24, and O26 (luteolin-7-O-glucoside) and O11, O20, and O22 (myricetin), respectively (Table 1), due to exploring the most electronegative atoms from those adsorbed onto the surface of (6,6) armchair CNT, which represented the maximal shift in TMS B3LYP/6-311+G(2d,p) (Figure 1a–f).
CS tensors were yielded by the quantum chemical calculations in the principal axes system to estimate the isotropic chemical shielding (CSI) and anisotropic chemical shielding (CSA) based on the following equations [44,45,46]:
CSI (ppm) = (σ33 + σ22 + σ11)/3
CSA (ppm) = σ33 − (σ22 + σ11)/2
Additionally, the Onsager model influenced the nuclear magnetic resonance data and chemical shielding of hydrogen, carbon, and oxygen atoms in (+)-catechin, betulinic acid, ursolic acid, quercetin-3-O-galactoside, luteolin-7-O-glucoside, and myricetin, adsorbed onto the surface of (6,6) armchair CNT (Figure 1a–f,a’–f’).
Moreover, the electrostatic potential map (ESP) was exhibited, which indicated the region including the attractive–repulsive force of a fix charge at different points in space that were parallel from a molecular surface of (+)-catechin, betulinic acid, ursolic acid, quercetin-3-O-galactoside, luteolin-7-O-glucoside, and myricetin in Sarracenia purpurea (Figure 1a–f).
The single-walled (6,6) armchair carbon nanotube was used as an additive to enhance the magnetic and electric sensitivities. These results were attributed to the excellent electromagnetic conductivity of the carbon nanostructure. The recommended mechanism of drug delivery involved (+)-catechin, betulinic acid, ursolic acid, quercetin-3-O-galactoside, luteolin-7-O-glucoside, and myricetin being calculated under the effect of the carbon nanotube and thereby releasing the drug.

3.2. Charge Transfer

Moreover, the results of atomic charge (Q) in Table 1 in a polar medium of water solution indicated the stability of (+)-catechin, betulinic acid, ursolic acid, quercetin-3-O-galactoside, luteolin-7-O-glucoside, and myricetin in Sarracenia purpurea drug joint to the surface of (6,6) armchair SWCNT as a drug delivery technique for treating the monkeypox disease (Figure 2).
Figure 2 suggests that the reasons for the various existing observed results of (+)-catechin, betulinic acid, ursolic acid, quercetin-3-O-galactoside, luteolin-7-O-glucoside, and myricetin adsorbed onto the surface of (6,6) armchair SWCNT were principally bound to the position of the active sites of labeled hydrogen, carbon, and oxygen, which move the charge of electrons in these compounds in polar water molecules. In fact, the partial charges were obtained by fitting the electrostatic potential with a correlation coefficient of R2 = 0.9634 to fixed charges of H, C, and O atoms of (+)-catechin, betulinic acid, ursolic acid, quercetin-3-O-galactoside, luteolin-7-O-glucoside, and myricetin, which were adsorbed onto the surface of (6,6) armchair CNT. Therefore, we assessed the electrophilic side chains of (+)-catechin, betulinic acid, ursolic acid, quercetin-3-O-galactoside, luteolin-7-O-glucoside, and myricetin in Sarracenia purpurea medicinal plant to find the reason for the activity and the stability of this drug against monkeypox virus activity.

3.3. Infrared Spectra Analysis

The results of the computational method of the infrared (IR) spectra were accomplished for (+)-catechin, betulinic acid, ursolic acid, quercetin-3-O-galactoside, luteolin-7-O-glucoside, and myricetin, adsorbed onto the surface of (6,6) armchair CNT, by using the B3LYP method and the 6-311+G (2d,p) basis set for atoms including hydrogen, carbon, and oxygen to obtain more accurate equilibrium geometrical parameters, thermodynamic properties and data for each of the determined structures. The IR spectra for (+)-catechin, betulinic acid, ursolic acid, quercetin-3-O-galactoside, luteolin-7-O-glucoside, and myricetin in Sarracenia purpurea drug were shown in the frequency range of about 250 cm−1–4500 cm−1 (Figure 3a–f). It can be seen that the strongest allowed peaks with the highest frequency occur around 1425 cm−1, 1650 cm−1, 1700 cm−1, 1725 cm−1, 1900 cm−1, 1925 cm−1, 1950 cm−1, 2100 cm−1, 2150 cm−1 ((+)-catechin); 250 cm−1, 650 cm−1, 1400 cm−1, and 2200 cm−1 (betulinic acid); 250 cm−1, 1400 cm−1, 1700 cm−1, 2200 cm−1, 3400 cm−1, and 3490 cm−1 (ursolic acid); 1300 cm−1, 1550 cm−1, 1700 cm−1, 1950 cm−1, 2150 cm−1, 2200 cm−1, and 3750 cm−1 (quercetin-3-O-galactoside); 1350 cm−1, 1800 cm−1, 1950 cm−1, 2150 cm−1, and 2200 cm−1 (luteolin-7-O-glucoside), and 1250 cm−1, 1450 cm−1, 1500 cm−1, 1525 cm−1, 1550 cm−1, 1900 cm−1, 1950 cm−1, 2000 cm−1, 2125 cm−1, 2150 cm−1, and 2200 cm−1 (myricetin), respectively (Figure 3a–f).
The spectra of Figure 3 demonstrate the reason for the existing observed various results for the frequencies of (+)-catechin, betulinic acid, ursolic acid, quercetin-3-O-galactoside, luteolin-7-O-glucoside, and myricetin, adsorbed onto the surface of (6,6) armchair CNT, which present the position of the active sites of labeled hydrogen, carbon, and oxygen in this drug (Scheme 1). These transfer the charge of electrons in polar (+)-catechin, betulinic acid, ursolic acid, quercetin-3-O-galactoside, luteolin-7-O-glucoside, and myricetin as adsorbates in water toward the surface of (6,6) the armchair carbon nanotube as an adsorbent (Scheme 2).
The results of physical and thermodynamic properties of dipole moment, ∆H, ∆G and ∆S for (+)-catechin, betulinic acid, ursolic acid, quercetin-3-O-galactoside, luteolin-7-O-glucoside, and myricetin, adsorbed onto the surface of (6,6) armchair CNT using the B3LYP/6-311+G(2d,p) method, are represented in Table 2 and Figure 4.
It was notable that polarization functions into the applied basis set in the computations always demonstrated a significant achievement in the simulation and modeling methods of theoretical levels. The normal modes of IR spectra were explored via harmonic potential wells by analytic methods which kept the movement of all atoms at the same time in the vibration time scale, leading to a natural definition of molecular vibrations (Table 2 and Figure 4).
The results of the above observations strongly suggested that (+)-catechin, betulinic acid, ursolic acid, quercetin-3-O-galactoside, luteolin-7-O-glucoside, and myricetin in Sarracenia purpurea medicinal plants, adsorbed onto the surface of (6,6) armchair SWCNT using the B3LYP/6-311+G(2d,p) method in a water solvent at 300 K, was predominantly due to basis set functions which were induced by a change in the polarity of the environment. As shown in Figure 4, a curve of degree 3 with the relation coefficient of R2 = 0.9002 proved that an increase in the dielectric constant enhanced the stability and the efficiency of this drug for treating the monkeypox disease.
In fact, single-walled carbon nanotubes reviewed in general physically adsorbed many of the organic molecules considered, and we ameliorated their detecting properties through chemisorption study.

3.4. HOMO and LUMO Analysis

The ionization caused the highest occupied molecular orbital (HOMO) energy and the electron affinity produced the lowest unoccupied molecular orbital (LUMO) energy. These were calculated and their results are reported for (+)-catechin, betulinic acid, ursolic acid, quercetin-3-O-galactoside, luteolin-7-O-glucoside, and myricetin in Table 3. The HOMO, LUMO and band energy gap (ev) presented the pictorial explanation of the frontier molecular orbitals and their respective positive and negative zones, which were important factors for identifying the molecular characteristics of effective compounds in Sarracenia purpurea drugs.
In fact, the HOMO showed the capability to give an electron while the LUMO as an electron acceptor exhibited the capability to achieving an electron. Therefore, the energy gap (∆E = E LUMO − EHOMO) indicated the energy difference between frontier HOMO and LUMO orbital, which introduced stability to the structure and unraveled the chemical activity of the molecule. In this paper, the energy gap established how (+)-catechin, betulinic acid, ursolic acid, quercetin-3-O-galactoside, luteolin-7-O-glucoside, and myricetin interacted with the surface of (6,6) armchair CNT. Besides, frontier molecular orbitals ran an important function in the optical and electrical properties, like in UV-VIS spectra [47].
Figure 5 demonstrates the changes in energy gap (E LUMO − EHOMO) versus various effective compounds in Sarracenia purpurea medicinal plant consisting of (+)-catechin, betulinic acid, ursolic acid, quercetin-3-O-galactoside, luteolin-7-O-glucoside, and myricetin, adsorbed onto the surface of (6,6) armchair CNT using the B3LYP/6-311+G(2d,p) quantum method.
Additionally, in order to obtain more conclusive approval in identifying the compound characteristics of these structures, a series of chemical reactivity parameters like chemical potential (µ), electronegativity (χ), hardness (η), softness (ζ), electrophilicity index (ψ) was designed using the following equations (Table 4) [48,49,50]:
µ = (EHOMO + ELUMO)/2
χ = – (EHOMO + ELUMO)/2
η = (ELUMO − EHOMO)/2
ζ = 1/(2η)
ψ = µ2/(2η)
The negative amounts of the chemical potential (µ) and the positive values of other quantities exhibited a good stability of (+)-catechin, betulinic acid, ursolic acid, quercetin-3-O-galactoside, luteolin-7-O-glucoside, and myricetin in Sarracenia purpurea drug through adsorption onto the surface of (6,6) armchair CNT correlated with the trend of drug delivery (Figure 6). These stable complexes of these compounds with Monkeypox protein virus illustrated the molecular drug delivery.

3.5. UV-VIS Spectroscopies

The energy gap between HOMO and LUMO distinguished the attributes of molecular electrical transport [51]. Through the Frank–Condon principle, the maximum absorption peak (max) depended on an ultraviolet–visible (UV-VIS) spectrum to vertical excitation.
In this verdict, TD-DFT/6-311+G (2d,p) computations were performed to identify the low-lying excited states of (+)-catechin, betulinic acid, ursolic acid, quercetin-3-O-galactoside, luteolin-7-O-glucoside, and myricetin in Sarracenia purpurea drug. The results consist of the vertical excitation energies, oscillator strength and wavelength introduced in Figure 7a–f.
In the computed amounts of ultraviolet–visible (UV-VIS) spectra for (+)-catechin, betulinic acid, ursolic acid, quercetin-3-O-galactoside, luteolin-7-O-glucoside, and myricetin extracted from Sarracenia purpurea drug, there were maximum adsorption bands between 200 nm–300 nm for (+)-catechin, betulinic acid, ursolic acid with a sharpest peak around 230 nm (Figure 7a–c); and maximum adsorption bands between 200 nm–400 nm for quercetin-3-O-galactoside, luteolin-7-O-glucoside, and myricetin, with the sharpest peak being around 300 nm, respectively (Figure 7d–f). In fact, the intensity of the absorbance of the single-walled (6,6) armchair carbon nanotube was analyzed for (+)-catechin, betulinic acid, ursolic acid, quercetin-3-O-galactoside, luteolin-7-O-glucoside, and myricetin from Sarracenia purpurea drug by using ultraviolet-visible (UV-VIS absorption spectroscopy. All nanotubes followed the Lambert–Beer law and indicated similar extinction coefficients irrepective of their structure.
Furthermore, the varieties of theoretical methods were discussed due to comparing density and energies with two approaches of AMBER via Monte Carlo (MC) optimization in water by using a hyperchem professional (7.01) program package. Therefore, the Monte Carlo energies versus time for betulinic acid, (+)-catechin, luteolin-7-O-glucoside, myricetin, quercetin-3-O-galactoside, and ursolic acid, adsorbed onto the surface of (6,6) armchair SWCNT in water medium at 300 K, are plotted in Figure 8.
The simulation of betulinic acid, (+)-catechin, luteolin-7-O-glucoside, myricetin, quercetin-3-O-galactoside, and ursolic acid, adsorbed onto the surface of (6,6) armchair SWCNT, showed that the stabilization energy of these compounds was affected by the Monte Carlo force field and temperature in medium of water.

4. Conclusions

Sarracenia purpurea as a medicinal plant can be applied in the prevention the monkeypox virus through the adsorption of its several effective compounds including (+)-catechin, betulinic acid, ursolic acid, quercetin-3-O-galactoside, luteolin-7-O-glucoside, and myricetin onto the surface of (6,6) armchair single-walled carbon nanotube as the drug delivery model. This is due to the direct electron transfer principle, which was studied by density functional theory (DFT) methods.
On the other hand, we used the B3LYP/6-311+G (2d,p) level of theory to evaluate the aptitude of SWCNT in adsorbing the effective compounds in Sarracenia purpurea medicinal plant through nuclear magnetic resonance and thermodynamic parameters. In fact, the achieved results represented that the feasibility of using (6,6) armchair SWCNT and these compounds became the norm in the drug delivery system which was attained by quantum calculations due to the physico-chemical properties of NMR and IR spectroscopy [52].
Additionally, the energy gap analysis of HOMO–LUMO illustrated the charge distribution in the frontier molecular orbitals of (+)-catechin, betulinic acid, ursolic acid, quercetin-3-O-galactoside, luteolin-7-O-glucoside, and myricetin in Sarracenia purpurea drug through adsorption onto the surface of (6,6) armchair carbon nanotube (CNT).

Funding

This research received no external funding.

Data Availability Statement

Not applicable.

Acknowledgments

In successfully completing this paper and its research, the authors are grateful to Kastamonu University for their support through the office, library, and scientific websites.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Petersen, B.W.; Damon, I.K. Smallpox, monkeypox and other poxvirus infections. In Goldman-Cecil Medicine, 26th ed.; Lee, G., Andrew, I.S., Eds.; Elsevier: Philadelphia, PA, USA, 2020; Volume 2, pp. 2180–2183. ISBN 978-0-323-53266-2. [Google Scholar]
  2. Sutcliffe, C.G.; Rimone, A.W.; Moss, W.J. Poxviruses. In Hunter’s Tropical Medicine and Emerging Infectious Diseases E-Book, 10th ed.; Ryan, E.T., Hill, D.R., Solomon, T., Aronson, N., Endy, T.P., Eds.; Elsevier: Edinburgh, UK, 2020; pp. 272–277. ISBN 978-0-323-55512-8. [Google Scholar]
  3. Harris, E. What to Know About Monkeypox. JAMA 2022, 327, 2278–2279. [Google Scholar] [CrossRef] [PubMed]
  4. Simpson, K.; Heymann, D.; Brown, C.S.; Edmunds, W.J.; Elsgaard, J.; Fine, P.; Hochrein, H.; Hoff, N.A.; Green, A.; Ihekweazu, C.; et al. Human monkeypox—After 40 years, an unintended consequence of smallpox eradication. Vaccine 2020, 38, 5077–5081. [Google Scholar] [CrossRef] [PubMed]
  5. Bunge, E.M.; Hoet, B.; Chen, L.; Lienert, F.; Weidenthaler, H.; Baer, L.R.; Steffen, R. The changing epidemiology of human monkeypox-A potential threat? A systematic review. PLoS Negl. Trop. Dis. 2022, 16, e0010141. [Google Scholar] [CrossRef]
  6. Minasov, G.; Inniss, N.L.; Shuvalova, L.; Anderson, W.F.; Satchell, K.J.F. Structure of the Monkeypox virus profilin-like protein A42R reveals potential functional differences from cellular profilins. Acta Crystallogr. F Struct. Biol. Commun. 2022, 78, 371–377. [Google Scholar] [CrossRef]
  7. Barlow, G.; Irving, W.L.; Moss, P.J. Infectious disease. In Kumar and Clark’s Clinical Medicine, 10th ed.; Feather, A., Randall, D., Waterhouse, M., Eds.; Elsevier: Amsterdam, The Netherlands, 2020; p. 517. ISBN 978-0-7020-7870-5. [Google Scholar]
  8. Hutin, Y.J.; Williams, R.J.; Malfait, P.; Pebody, R.; Loparev, V.N.; Ropp, S.L.; Rodriguez, M.; Knight, J.C.; Tshioko, F.K.; Khan, A.S.; et al. Outbreak of human monkeypox, Democratic Republic of Congo, 1996 to 1997. Emerg. Infect. Dis. 2001, 7, 434–438. [Google Scholar] [CrossRef]
  9. Arndt, W.; Mitnik, C.; Denzler, K.L.; White, S.; Waters, R.; Jacobs, B.L.; Rochon, Y.; Olson, V.A.; Damon, I.K.; Langland, J.O. In Vitro Characterization of a Nineteenth-Century Therapy for Smallpox. PLoS ONE 2012, 7, e32610. [Google Scholar] [CrossRef]
  10. Nadar, S.; Khan, T.; Omri, A. Reemergence of monkeypox: Prevention and management. Expert Rev. Anti-Infect. Ther. 2022, 20, 1425–1433. [Google Scholar] [CrossRef]
  11. Abubakar, I.B.; Kankara, S.S.; Malami, I.; Danjuma, J.B.; Muhammad, Y.Z.; Yahaya, H.; Singh, D.; Usman, U.J.; Ukwuani-Kwaja, A.N.; Muhammad, A.; et al. Traditional medicinal plants used for treating emerging and re-emerging viral diseases in northern Nigeria. Eur. J. Integr. Med. 2022, 49, 102094. [Google Scholar] [CrossRef]
  12. Millspaugh, C.F. American Medicinal Plants: An Illustrated and Descriptive Guide to Plants Indigenous to and Naturalized in the United States Which Are Used in Medicine (Illustrated ed.); Courier Corporation: Chelmsford, MA, USA, 1892; p. 76. ISBN 9780486230344. [Google Scholar]
  13. Mollaamin, F.; Monajjemi, M. Thermodynamic research on the inhibitors of coronavirus through drug delivery method. J. Chil. Chem. Soc. 2021, 66, 5195–5205. [Google Scholar] [CrossRef]
  14. Tiwari, G.; Tiwari, R.; Sriwastawa, B.; Bhati, L.; Pandey, S.; Pandey, P.; Bannerjee, S.K. Drug delivery systems: An updated review. Int. J. Pharm. Investig. 2012, 2, 2–11. [Google Scholar] [CrossRef]
  15. Monajjemi, M.; Shahriari, S. Fatemeh Mollaamin, Evaluation of Coronavirus Families & Covid-19 Proteins: Molecular Modeling Study. Biointerface Res. Appl. Chem. 2020, 10, 6039–6057. [Google Scholar] [CrossRef]
  16. Mollaamin, F. On the behavior of boron nitride Nanotube-Flavin adenine Dinucleotide interaction ion implantation order to design Biofuel cells. J. Comput. Theor. Nanosci. 2014, 11, 2017–2022. [Google Scholar] [CrossRef]
  17. Monajjemi, M.; Honaparvar, B.; Khalili Hadad, B.; Ilkhani, A.; Mollaamin, F. Thermo-Chemical Investigation and NBO Analysis of Some anxileotic as Nano- Drugs. Afr. J. Pharm. Pharmacol. 2010, 4, 521–529. [Google Scholar]
  18. Singh, A.P.; Biswas, A.; Shukla, A.; Maiti, P. Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles. Signal Transduct. Target. Ther. 2019, 4, 33. [Google Scholar] [CrossRef]
  19. Mollaamin, F.; Monajjemi, M. Harmonic Linear Combination and Normal Mode Analysis of Semiconductor Nanotubes Vibrations. J. Comput. Theor. Nanosci 2015, 12, 1030–1039. [Google Scholar] [CrossRef]
  20. Khaleghian, M.; Zahmatkesh, M.; Mollaamin, F.; Monajjemi, M. Investigation of Solvent Effects on Armchair Single-Walled Carbon Nanotubes: A QM/MD Study. Fuller. Nanotub. Carbon Nanostructures 2011, 19, 251–261. [Google Scholar] [CrossRef]
  21. Ghalandari, B.; Monajjemi, M.; Mollaamin, F. Theoretical Investigation of Carbon Nanotube Binding to DNA in View of Drug Delivery. J. Comput. Theor. Nanosci. 2011, 8, 1212–1219. [Google Scholar] [CrossRef]
  22. Khalili Hadad, B.; Mollaamin, F.; Monajjemi, M. Biophysical chemistry of macrocycles for drug delivery: A theoretical study. Russ. Chem. Bull. 2011, 60, 238–241. [Google Scholar] [CrossRef]
  23. Sarasia, E.M.; Afsharnezhad, S.; Honarparvar, B.; Mollaamin, F.; Monajjemi, M. Theoretical study of solvent effect on NMR shielding tensors of luciferin derivatives. Phys. Chem. Liquids 2011, 49, 561–571. [Google Scholar] [CrossRef]
  24. Mollaamin, F. Physicochemical Investigation of Anti-COVID19 Drugs Using Several Medicinal Plants. J. Chil. Chem. Soc. 2022, 67, 5537–5546. [Google Scholar] [CrossRef]
  25. Mahdavian, L.; Monajjemi, M. Alcohol sensors based on SWNT as chemical sensors: Monte Carlo and Langevin dynamics simulation. Microelectron. J. 2010, 41, 142–149. [Google Scholar] [CrossRef]
  26. Monajjemi, M.; Baheri, H.; Mollaamin, F. A percolation model for carbon nanotube-polymer composites using the Mandelbrot-Given. J. Struct. Chem. 2011, 52, 54–59. [Google Scholar] [CrossRef]
  27. Tahan, A.; Mollaamin, F.; Monajjemi, M. Thermochemistry and NBO analysis of peptide bond: Investigation of basis sets and binding energy. Russ. J. Phys. Chem. A 2009, 83, 587–597. [Google Scholar] [CrossRef]
  28. Frisch, M.J.; Trucks, G.W.; Schlegel, H.B.; Scuseria, G.E.; Robb, M.A.; Cheeseman, J.R.; Scalmani, G.; Barone, V.; Petersson, G.A.; Nakatsuji, H.; et al. Gaussian 16, Revision C.01; Gaussian, Inc.: Wallingford, CT, USA, 2016. [Google Scholar]
  29. Lee, C.; Yang, W.; Parr, R.G. Development of the Colle-Salvetti Correlation-Energy Formula into a Functional of the Electron Density. Phys. Rev. B 1988, 37, 785–789. [Google Scholar] [CrossRef]
  30. Koch, W.; Holthausen, M.C. A Chemist’s Guide to Density Functional Theory, 2nd ed.; Wiley-VCH: Weinheim, Germany, 2000; Volume 3–64, pp. 93–104. [Google Scholar]
  31. Becke, A.D. Density-Functional Exchange-Energy Approximation with Correct Asymptotic Behavior. Phys. Rev. A 1988, 38, 3098–3100. [Google Scholar] [CrossRef]
  32. Bakhshi, K.; Mollaamin, F.; Monajjemi, M. Exchange and correlation effect of hydrogen chemisorption on nano V(100) surface: A DFT study by generalized gradient approximation (GGA). J. Comput. Theor. Nanosci. 2011, 8, 763–768. [Google Scholar] [CrossRef]
  33. Monajjemi, M.; Khaleghian, M.; Tadayonpour, N.; Mollaamin, F. The effect of different solvents and temperatures on stability of single-walled carbon nanotube: A QM/MD study. Int. J. Nanosci. 2010, 9, 517–529. [Google Scholar] [CrossRef]
  34. Cramer, C.J.; Truhlar, D.G. PM3-SM3: A general parameterization for including aqueous solvation effects in the PM3 molecular orbital model. J. Comp. Chem. 1992, 13, 1089–1097. [Google Scholar] [CrossRef]
  35. Liotard, D.A.; Hawkins, G.D.; Lynch, G.C.; Cramer, C.J.; Truhlar, D.G. Improved methods for semiempirical solvation models. J. Comp. Chem. 1995, 16, 422–440. [Google Scholar] [CrossRef]
  36. Chambers, C.C.; Hawkins, G.D.; Cramer, C.J.; Truhlar, D.G. Model for aqueous solvation based on class IV atomic charges and first solvation shell effects. J. Phys. Chem. 1996, 100, 16385–16398. [Google Scholar] [CrossRef]
  37. Giesen, D.J.; Gu, M.Z.; Cramer, C.J.; Truhlar, D.G. A Universal Organic Solvation Model. J. Org. Chem. 1996, 61, 8720–8721. [Google Scholar] [CrossRef] [PubMed]
  38. Onsager, L.J. Electric Moments of Molecules in Liquids. J. Am. Chem. Soc. 1936, 58, 1486–1493. [Google Scholar] [CrossRef]
  39. Tomasi, J. Cavity and reaction field: “Robust” concepts. Perspective on “Electric moments of molecules in liquids”. Theor. Chem. Acc. 2000, 103, 196–199. [Google Scholar] [CrossRef]
  40. Zadeh, M.A.A.; Lari, H.; Kharghanian, L.; Balali, E.; Khadivi, R.; Yahyaei, H.; Mollaamin, F.; Monajjemi, M. Density functional theory study and anti-cancer properties of shyshaq plant: In view point of nano biotechnology. J. Comput. Theor. Nanosci. 2015, 12, 4358–4367. [Google Scholar] [CrossRef]
  41. Mollaamin, F.; Monajjemi, M.; Salemi, S.; Baei, M.T. A Dielectric Effect on Normal Mode Analysis and Symmetry of BNNT Nanotube. Fuller. Nanotub. Carbon Nanostructures 2011, 19, 182–196. [Google Scholar] [CrossRef]
  42. Mollaamin, F.; Ilkhani, A.; Sakhaei, N.; Bonsakhteh, B.; Faridchehr, A.; Tohidi, S.; Monajjemi, M.; Fatemeh, M.; Alireza, I.; Neda, S.; et al. Thermodynamic and solvent effect on dynamic structures of nano bilayer-cell membrane: Hydrogen bonding study. J. Comput. Theor. Nanosci. 2015, 12, 3148–3154. [Google Scholar] [CrossRef]
  43. Mollaamin, F. Chemotherapy Study of alkaloids through Theoretical Quantum Methods. Moroc. J. Chemistry. 2020, 8, 400–411. [Google Scholar] [CrossRef]
  44. Fry, R.A.; Kwon, K.D.; Komarneni, S.; Kubicki, J.D.; Mueller, K.T. Solid-State NMR and Computational Chemistry Study of Mononucleotides Adsorbed to Alumina. Langmuir 2006, 22, 9281–9286. [Google Scholar] [CrossRef]
  45. Monajjemi, M.; Noei, M.; Mollaamin, F. Design of fMet-tRNA and Calculation of its Bonding Properties by Quantum Mechanics. Nucleosides Nucleotides Nucleic Acids 2010, 29, 676–683. [Google Scholar] [CrossRef]
  46. Monajjemi, M.; Robert, W.J.; Boggs, J.E. NMR contour maps as a new parameter of carboxyl’s OH groups in amino acids recognition: A reason of tRNA-amino acid conjugation. Chem. Phys. 2014, 433, 1–11. [Google Scholar] [CrossRef]
  47. Aihara, J. Reduced HOMO−LUMO Gap as an Index of Kinetic Stability for Polycyclic Aromatic Hydrocarbons. J. Phys. Chem. A 1999, 103, 7487–7495. [Google Scholar] [CrossRef]
  48. Kohn, W.; Becke, A.D.; Parr, R.G. Density Functional Theory of Electronic Structure. J. Phys. Chem. 1996, 100, 12974–12980. [Google Scholar] [CrossRef]
  49. Parr, R.G.; Pearson, R.G. Absolute Hardness: Companion Parameter to Absolute Electronegativity. J. Am. Chem. Soc. 1983, 105, 7512–7516. [Google Scholar] [CrossRef]
  50. Politzer, P.; Abu-Awwad, F. A comparative analysis of Hartree-Fock and Kohn-Sham orbital energies. Theor. Chem. Acc. 1998, 99, 83–87. [Google Scholar] [CrossRef]
  51. Silverstein, R.M.; Bassler, G.C.; Morrill, T.C. Spectrometric Identification of Organic Compounds, 5th ed.; John Wiley & Sons, Inc.: New York, NY, USA, 1981. [Google Scholar]
  52. Mollaamin, F. Features of Parametric Point Nuclear Magnetic Resonance of Metals Implantation on Boron Nitride Nanotube by Density Functional Theory/Electron Paramagnetic Resonance. J. Comput. Theor. Nanosci. 2014, 11, 2393–2398. [Google Scholar] [CrossRef]
Computation 11 00084 sch001
Scheme 1. 3D structure of Monkeypox virus with two chains of A and B, MSE protein, Ramachandran Plot and substitution of serine with methionine in the target.
Scheme 1. 3D structure of Monkeypox virus with two chains of A and B, MSE protein, Ramachandran Plot and substitution of serine with methionine in the target.
Computation 11 00084 sch001
Computation 11 00084 sch002
Scheme 2. Mechanism of adsorption of luteolin-7-O-glucoside onto the surface of (6,6) armchair SWCNT in a water medium at 300 K.
Scheme 2. Mechanism of adsorption of luteolin-7-O-glucoside onto the surface of (6,6) armchair SWCNT in a water medium at 300 K.
Computation 11 00084 sch002
Computation 11 00084 g001aComputation 11 00084 g001b
Figure 1. The graph of NMR spectra of isotropic (σiso), anisotropic (σaniso) shielding tensors calculated by level of theory B3LYP/6-311+G(2d,p) for (a) (+)-catechin, (a’) (+)-catechin→CNT, (b) betulinic acid, (b’) betulinic acid→CNT, (c) ursolic acid, (c’) ursolic acid→CNT, (d) quercetin-3-O-galactoside, (d’) quercetin-3-O-galactoside→CNT, (e) luteolin-7-O-glucoside, (e’) luteolin-7-O-glucoside→CNT, (f) myricetin and (f’) myricetin→CNT.
Figure 1. The graph of NMR spectra of isotropic (σiso), anisotropic (σaniso) shielding tensors calculated by level of theory B3LYP/6-311+G(2d,p) for (a) (+)-catechin, (a’) (+)-catechin→CNT, (b) betulinic acid, (b’) betulinic acid→CNT, (c) ursolic acid, (c’) ursolic acid→CNT, (d) quercetin-3-O-galactoside, (d’) quercetin-3-O-galactoside→CNT, (e) luteolin-7-O-glucoside, (e’) luteolin-7-O-glucoside→CNT, (f) myricetin and (f’) myricetin→CNT.
Computation 11 00084 g001aComputation 11 00084 g001b
Computation 11 00084 g002
Figure 2. The fluctuation of atomic charge (Q) of hydrogen, carbon and oxygen atoms in the active sites of (+)-catechin, betulinic acid, ursolic acid, quercetin-3-O-galactoside, luteolin-7-O-glucoside, and myricetin.
Figure 2. The fluctuation of atomic charge (Q) of hydrogen, carbon and oxygen atoms in the active sites of (+)-catechin, betulinic acid, ursolic acid, quercetin-3-O-galactoside, luteolin-7-O-glucoside, and myricetin.
Computation 11 00084 g002
Computation 11 00084 g003aComputation 11 00084 g003b
Figure 3. The infrared spectra of effective compounds in Sarracenia purpurea drug including (a) (+)-catechin, (b) betulinic acid, (c) ursolic acid, (d) quercetin-3-O-galactoside, (e) luteolin-7-O-glucoside, and (f) myricetin adsorbed onto the surface of (6,6) armchair CNT by using 6-311+G(2d,p) calculations.
Figure 3. The infrared spectra of effective compounds in Sarracenia purpurea drug including (a) (+)-catechin, (b) betulinic acid, (c) ursolic acid, (d) quercetin-3-O-galactoside, (e) luteolin-7-O-glucoside, and (f) myricetin adsorbed onto the surface of (6,6) armchair CNT by using 6-311+G(2d,p) calculations.
Computation 11 00084 g003aComputation 11 00084 g003b
Computation 11 00084 g004
Figure 4. The changes in Gibbs free energy (∆G) for (+)-catechin, betulinic acid, ursolic acid, quercetin-3-O-galactoside, luteolin-7-O-glucoside, and myricetin adsorbed onto the surface of (6,6) armchair CNT using B3LYP/6-311+G(2d,p) quantum calculation.
Figure 4. The changes in Gibbs free energy (∆G) for (+)-catechin, betulinic acid, ursolic acid, quercetin-3-O-galactoside, luteolin-7-O-glucoside, and myricetin adsorbed onto the surface of (6,6) armchair CNT using B3LYP/6-311+G(2d,p) quantum calculation.
Computation 11 00084 g004
Computation 11 00084 g005
Figure 5. The energy gap (ev) of HOMO–LUMO for (+)-catechin, betulinic acid, ursolic acid, quercetin-3-O-galactoside, luteolin-7-O-glucoside, and myricetin in Sarracenia purpurea drug.
Figure 5. The energy gap (ev) of HOMO–LUMO for (+)-catechin, betulinic acid, ursolic acid, quercetin-3-O-galactoside, luteolin-7-O-glucoside, and myricetin in Sarracenia purpurea drug.
Computation 11 00084 g005
Computation 11 00084 g006
Figure 6. Changes in chemical potential (µ), electronegativity (χ), hardness (η), softness (ζ), electrophilicity index (ψ) for (+)-catechin, betulinic acid, ursolic acid, quercetin-3-O-galactoside, luteolin-7-O-glucoside, and myricetin.
Figure 6. Changes in chemical potential (µ), electronegativity (χ), hardness (η), softness (ζ), electrophilicity index (ψ) for (+)-catechin, betulinic acid, ursolic acid, quercetin-3-O-galactoside, luteolin-7-O-glucoside, and myricetin.
Computation 11 00084 g006
Computation 11 00084 g007aComputation 11 00084 g007bComputation 11 00084 g007c
Figure 7. The UV-VIS spectra of (a) (+)-catechin, (b) betulinic acid, (c) ursolic acid, (d) quercetin-3-O-galactoside, (e) luteolin-7-O-glucoside, and (f) myricetin in Sarracenia purpurea drug.
Figure 7. The UV-VIS spectra of (a) (+)-catechin, (b) betulinic acid, (c) ursolic acid, (d) quercetin-3-O-galactoside, (e) luteolin-7-O-glucoside, and (f) myricetin in Sarracenia purpurea drug.
Computation 11 00084 g007aComputation 11 00084 g007bComputation 11 00084 g007c
Computation 11 00084 g008
Figure 8. Potential energy (kcal/mol) versus time for betulinic acid, (+)-catechin, luteolin-7-O-glucoside, myricetin, quercetin-3-O-galactoside, and ursolic acid in water at 300 K extracted from Monte Carle simulation method.
Figure 8. Potential energy (kcal/mol) versus time for betulinic acid, (+)-catechin, luteolin-7-O-glucoside, myricetin, quercetin-3-O-galactoside, and ursolic acid in water at 300 K extracted from Monte Carle simulation method.
Computation 11 00084 g008
Table 1. The results of SCF GIAO magnetic shielding tensor and atomic charge (Q) for (+)-catechin, betulinic acid, ursolic acid, quercetin-3-O-galactoside, luteolin-7-O-glucoside, and myricetin in ppm joint at the adsorption site of (6,6) armchair CNT.
Table 1. The results of SCF GIAO magnetic shielding tensor and atomic charge (Q) for (+)-catechin, betulinic acid, ursolic acid, quercetin-3-O-galactoside, luteolin-7-O-glucoside, and myricetin in ppm joint at the adsorption site of (6,6) armchair CNT.
(+)-catechin
ppmC9O10C16O17C18O19H29H32H33
σ1159.2865290.705783.3679294.788974.8748314.002122.013918.399422.5452
σ2295.0440290.705796.1147319.9473102.1597334.349729.167630.990029.3964
σ33202.1101324.1978204.8543371.6628204.9966339.334140.102339.039740.7560
σiso118.8135312.0269128.1123328.7997127.3437329.228730.427929.476430.8992
σaniso124.944918.2563115.113064.2947116.479315.158214.511614.345014.7852
Q0.1421−0.29010.116237−0.29610.098471−0.30900.21380.22580.2213
betulinic acid
ppmC1C15O16O32O33H55H56H81
σ11−15.6362169.1082328.6384−503.6711138.869828.031424.829721.7177
σ22154.9603178.9003337.9158−252.2589310.123229.958831.625524.5804
σ33164.7082209.4747421.9830450.9700335.304337.496949.644938.4823
σiso101.3441185.8277362.8457−101.6533261.432431.829035.366728.2601
σaniso95.046235.470488.7059828.9350110.80788.501821.417315.3332
Q0.31710.0872−0.3262−0.2893−0.31300.03170.18430.2175
ursolic acid
ppmC1C2O3O32O33H34H35H81
σ11−14.8985170.5948339.4528−466.2527149.881427.252324.146322.1181
σ22159.4348178.9689347.9330−229.8480312.0712 28.427831.820524.5591
σ33163.0061206.2026420.4447448.6102332.291639.602648.353138.8056
σiso102.5141185.2554369.2768−82.4968264.748131.7609 34.773328.4942
σaniso90.738031.420776.7519796.6605101.315311.762620.369715.4670
Q0.32220.0873−0.3302−0.2924−0.31530.03420.18800.2168
quercetin-3-O-galactoside
ppmC9O10C16O17C18O19H36H39H40
σ1154.5792281.019676.6664302.960883.8594322.199621.598918.901022.7514
σ2292.8624322.370597.9617319.2503118.3675329.450929.587630.587329.1195
σ33201.6165322.7628207.5362372.0312203.9020342.707038.888538.902040.9307
σiso116.3527308.7176127.3881331.4141135.3763331.452530.025029.463430.9339
σaniso127.895721.0677120.222160.9256135.376316.881813.295314.157914.9952
Q0.1521−0.28680.1158−0.29580.0999−0.30380.21870.22470.2208
luteolin-7-O-glucoside
ppmC15O16C17O18C23O24C25O26H38H39
σ1180.5725298.634571.3881308.1253178.5325345.1945175.2961349.220818.120822.3625
σ2299.5240320.621199.9390331.7684185.8453355.1242183.8870 360.380531.104329.0165
σ33203.2873369.2133204.0323340.0012214.9455417.7007210.8215419.994039.162640.6486
σiso127.7946329.4896125.1198326.6316193.1078372.6731190.0015376.531729.462630.6759
σaniso113.239159.5854118.368820.054432.756667.541331.230065.193314.550114.9591
Q0.1113−0.29770.1043−0.30650.0689−0.31630.0671−0.32890.22410.2229
myricetin
ppmC10O11C12C19O20O22H27H28H31H32
σ1153.5046279.347599.668297.7369313.5489316.099221.641519.802018.554222.3030
σ2292.4576322.1245142.5628101.4764329.1589334.061729.343530.244631.294329.8787
σ33201.7495322.9617223.6607205.2742387.8727337.055938.914431.449739.452440.5172
σiso115.9039308.1446155.2972134.8292343.5269 329.072329.966527.165429.767030.8996
σaniso128.768422.2257102.5452105.667566.518811.975413.42196.426414.528214.4263
Q0.1544−0.2859−0.12400.0836−0.3111-0.30860.22000.05800.23430.2219
Table 2. The results of calculated thermodynamic properties of ∆G, ∆H (kcal/mol) and ∆S (cal/mol.K−1) in water at 300 K.
Table 2. The results of calculated thermodynamic properties of ∆G, ∆H (kcal/mol) and ∆S (cal/mol.K−1) in water at 300 K.
Compounds∆G × 10−3∆H × 10−3∆SDipole Moment (Debye)
(+)-catechin−634.993−634.958117.2702.3245
betulinic acid−860.291−860.242161.6001.5023
ursolic acid−860.275−860.229151.4791.4017
quercetin-3-O-galactoside−1055.740−1055.697142.2875.4546
luteolin-7-O-glucoside−1009.555−1009.514138.4485.4520
myricetin−726.155−957.555112.0432.2361
Table 3. The HOMO, LUMO and band energy gap (ev) for effective compounds of (+)-catechin, betulinic acid, ursolic acid, quercetin-3-O-galactoside, luteolin-7-O-glucoside, and myricetin in Sarracenia purpurea drug.
Table 3. The HOMO, LUMO and band energy gap (ev) for effective compounds of (+)-catechin, betulinic acid, ursolic acid, quercetin-3-O-galactoside, luteolin-7-O-glucoside, and myricetin in Sarracenia purpurea drug.
CompoundsELUMO (ev)EHOMO (ev)∆E = ELUMO – EHOMO (ev)
(+)-catechinComputation 11 00084 i001
−2.1960		Computation 11 00084 i002
−6.7125		4.5165
betulinic acidComputation 11 00084 i003
−3.5556		Computation 11 00084 i004
−7.6586		4.103
ursolic acidComputation 11 00084 i005
−3.6444		Computation 11 00084 i006
−7.0303		3.3859
quercetin-3-O-galactosideComputation 11 00084 i007
−1.0222		Computation 11 00084 i008
−5.4036		4.3814
luteolin-7-O-glucosideComputation 11 00084 i009
−1.8610		Computation 11 00084 i010
−5.7944		4.7722
myricetinComputation 11 00084 i011
−1.7644		Computation 11 00084 i012
−5.5318		3.7674
Table 4. Chemical potential (µ), electronegativity (χ), hardness (η), softness (ζ), electrophilicity index (ψ) for (+)-catechin, betulinic acid, ursolic acid, quercetin-3-O-galactoside, luteolin-7-O-glucoside, and myricetin.
Table 4. Chemical potential (µ), electronegativity (χ), hardness (η), softness (ζ), electrophilicity index (ψ) for (+)-catechin, betulinic acid, ursolic acid, quercetin-3-O-galactoside, luteolin-7-O-glucoside, and myricetin.
Compound Quantities (ev)(+)-catechinBetulinic AcidUrsolic Acidquercetin-3-O-galactosideluteolin-7-O-glucosideMyricetin
µ−4.45425−5.6071−5.33735−3.2129−3.8277−3.6481
χ4.454255.60715.337353.21293.82773.6481
η2.258252.05151.692952.19071.96671.8837
ζ0.22140.24370.29530.22820.25420.2654
ψ4.39287.66258.41352.35603.72483.5326
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Mollaamin, F. Computational Methods in the Drug Delivery of Carbon Nanocarriers onto Several Compounds in Sarraceniaceae Medicinal Plant as Monkeypox Therapy. Computation 2023, 11, 84. https://doi.org/10.3390/computation11040084

AMA Style

Mollaamin F. Computational Methods in the Drug Delivery of Carbon Nanocarriers onto Several Compounds in Sarraceniaceae Medicinal Plant as Monkeypox Therapy. Computation. 2023; 11(4):84. https://doi.org/10.3390/computation11040084

Chicago/Turabian Style

Mollaamin, Fatemeh. 2023. "Computational Methods in the Drug Delivery of Carbon Nanocarriers onto Several Compounds in Sarraceniaceae Medicinal Plant as Monkeypox Therapy" Computation 11, no. 4: 84. https://doi.org/10.3390/computation11040084

APA Style

Mollaamin, F. (2023). Computational Methods in the Drug Delivery of Carbon Nanocarriers onto Several Compounds in Sarraceniaceae Medicinal Plant as Monkeypox Therapy. Computation, 11(4), 84. https://doi.org/10.3390/computation11040084

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop